1 Swine Erysipelas Vaccine Market Overview 1.1 Product Overview and Scope of Swine Erysipelas Vaccine 1.2 Swine Erysipelas Vaccine Segment by Type 1.2.1 Global Swine Erysipelas Vaccine Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Live 1.2.3 Inactivated 1.3 Swine Erysipelas Vaccine Segment by Distribution Channel 1.3.1 Global Swine Erysipelas Vaccine Sales Comparison by Distribution Channel: (2021-2027) 1.3.2 Pharmacy 1.3.3 Online Sale 1.3.4 Others 1.4 Global Swine Erysipelas Vaccine Market Size Estimates and Forecasts 1.4.1 Global Swine Erysipelas Vaccine Revenue 2016-2027 1.4.2 Global Swine Erysipelas Vaccine Sales 2016-2027 1.4.3 Swine Erysipelas Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027 2 Swine Erysipelas Vaccine Market Competition by Manufacturers 2.1 Global Swine Erysipelas Vaccine Sales Market Share by Manufacturers (2016-2021) 2.2 Global Swine Erysipelas Vaccine Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Swine Erysipelas Vaccine Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Swine Erysipelas Vaccine Manufacturing Sites, Area Served, Product Type 2.5 Swine Erysipelas Vaccine Market Competitive Situation and Trends 2.5.1 Swine Erysipelas Vaccine Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Swine Erysipelas Vaccine Players Market Share by Revenue 2.5.3 Global Swine Erysipelas Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Swine Erysipelas Vaccine Retrospective Market Scenario by Region 3.1 Global Swine Erysipelas Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Swine Erysipelas Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Swine Erysipelas Vaccine Market Facts & Figures by Country 3.3.1 North America Swine Erysipelas Vaccine Sales by Country 3.3.2 North America Swine Erysipelas Vaccine Revenue by Country 3.3.3 United States 3.3.4 Canada 3.4 Europe Swine Erysipelas Vaccine Market Facts & Figures by Country 3.4.1 Europe Swine Erysipelas Vaccine Sales by Country 3.4.2 Europe Swine Erysipelas Vaccine Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Swine Erysipelas Vaccine Market Facts & Figures by Region 3.5.1 Asia Pacific Swine Erysipelas Vaccine Sales by Region 3.5.2 Asia Pacific Swine Erysipelas Vaccine Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 China Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.6 Latin America Swine Erysipelas Vaccine Market Facts & Figures by Country 3.6.1 Latin America Swine Erysipelas Vaccine Sales by Country 3.6.2 Latin America Swine Erysipelas Vaccine Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.6.6 Colombia 3.7 Middle East and Africa Swine Erysipelas Vaccine Market Facts & Figures by Country 3.7.1 Middle East and Africa Swine Erysipelas Vaccine Sales by Country 3.7.2 Middle East and Africa Swine Erysipelas Vaccine Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Swine Erysipelas Vaccine Historic Market Analysis by Type 4.1 Global Swine Erysipelas Vaccine Sales Market Share by Type (2016-2021) 4.2 Global Swine Erysipelas Vaccine Revenue Market Share by Type (2016-2021) 4.3 Global Swine Erysipelas Vaccine Price by Type (2016-2021) 5 Global Swine Erysipelas Vaccine Historic Market Analysis by Distribution Channel 5.1 Global Swine Erysipelas Vaccine Sales Market Share by Distribution Channel (2016-2021) 5.2 Global Swine Erysipelas Vaccine Revenue Market Share by Distribution Channel (2016-2021) 5.3 Global Swine Erysipelas Vaccine Price by Distribution Channel (2016-2021) 6 Key Companies Profiled 6.1 Zoetis 6.1.1 Zoetis Corporation Information 6.1.2 Zoetis Description and Business Overview 6.1.3 Zoetis Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Zoetis Swine Erysipelas Vaccine Product Portfolio 6.1.5 Zoetis Recent Developments/Updates 6.2 Merck 6.2.1 Merck Corporation Information 6.2.2 Merck Description and Business Overview 6.2.3 Merck Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Merck Swine Erysipelas Vaccine Product Portfolio 6.2.5 Merck Recent Developments/Updates 6.3 Boehringer Ingelheim 6.3.1 Boehringer Ingelheim Corporation Information 6.3.2 Boehringer Ingelheim Description and Business Overview 6.3.3 Boehringer Ingelheim Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Boehringer Ingelheim Swine Erysipelas Vaccine Product Portfolio 6.3.5 Boehringer Ingelheim Recent Developments/Updates 6.4 Qilu Animal Health 6.4.1 Qilu Animal Health Corporation Information 6.4.2 Qilu Animal Health Description and Business Overview 6.4.3 Qilu Animal Health Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Qilu Animal Health Swine Erysipelas Vaccine Product Portfolio 6.4.5 Qilu Animal Health Recent Developments/Updates 6.5 CAHIC 6.5.1 CAHIC Corporation Information 6.5.2 CAHIC Description and Business Overview 6.5.3 CAHIC Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.5.4 CAHIC Swine Erysipelas Vaccine Product Portfolio 6.5.5 CAHIC Recent Developments/Updates 6.6 Chengdu Tianbang Biology 6.6.1 Chengdu Tianbang Biology Corporation Information 6.6.2 Chengdu Tianbang Biology Description and Business Overview 6.6.3 Chengdu Tianbang Biology Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Chengdu Tianbang Biology Swine Erysipelas Vaccine Product Portfolio 6.6.5 Chengdu Tianbang Biology Recent Developments/Updates 6.7 Jiujiang Bomeilai Biological 6.6.1 Jiujiang Bomeilai Biological Corporation Information 6.6.2 Jiujiang Bomeilai Biological Description and Business Overview 6.6.3 Jiujiang Bomeilai Biological Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Jiujiang Bomeilai Biological Swine Erysipelas Vaccine Product Portfolio 6.7.5 Jiujiang Bomeilai Biological Recent Developments/Updates 6.8 Jilin Zhengye Biological 6.8.1 Jilin Zhengye Biological Corporation Information 6.8.2 Jilin Zhengye Biological Description and Business Overview 6.8.3 Jilin Zhengye Biological Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Jilin Zhengye Biological Swine Erysipelas Vaccine Product Portfolio 6.8.5 Jilin Zhengye Biological Recent Developments/Updates 6.9 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. 6.9.1 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Corporation Information 6.9.2 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Description and Business Overview 6.9.3 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Swine Erysipelas Vaccine Product Portfolio 6.9.5 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Recent Developments/Updates 6.10 Hunan Zhong'an Biological Pharmaceutical Co., Ltd. 6.10.1 Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Corporation Information 6.10.2 Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Description and Business Overview 6.10.3 Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Swine Erysipelas Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Swine Erysipelas Vaccine Product Portfolio 6.10.5 Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Recent Developments/Updates 7 Swine Erysipelas Vaccine Manufacturing Cost Analysis 7.1 Swine Erysipelas Vaccine Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Swine Erysipelas Vaccine 7.4 Swine Erysipelas Vaccine Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Swine Erysipelas Vaccine Distributors List 8.3 Swine Erysipelas Vaccine Customers 9 Swine Erysipelas Vaccine Market Dynamics 9.1 Swine Erysipelas Vaccine Industry Trends 9.2 Swine Erysipelas Vaccine Growth Drivers 9.3 Swine Erysipelas Vaccine Market Challenges 9.4 Swine Erysipelas Vaccine Market Restraints 10 Global Market Forecast 10.1 Swine Erysipelas Vaccine Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Swine Erysipelas Vaccine by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Swine Erysipelas Vaccine by Type (2022-2027) 10.2 Swine Erysipelas Vaccine Market Estimates and Projections by Distribution Channel 10.2.1 Global Forecasted Sales of Swine Erysipelas Vaccine by Distribution Channel (2022-2027) 10.2.2 Global Forecasted Revenue of Swine Erysipelas Vaccine by Distribution Channel (2022-2027) 10.3 Swine Erysipelas Vaccine Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Swine Erysipelas Vaccine by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Swine Erysipelas Vaccine by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Swine Erysipelas Vaccine Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Swine Erysipelas Vaccine Sales (K Units) Comparison by Distribution Channel (2021-2027) Table 3. Global Swine Erysipelas Vaccine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Swine Erysipelas Vaccine Covered in This Study Table 5. Global Swine Erysipelas Vaccine Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Swine Erysipelas Vaccine Sales Market Share by Manufacturers (2016-2021) Table 7. Global Swine Erysipelas Vaccine Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Swine Erysipelas Vaccine Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Swine Erysipelas Vaccine Average Price (US$/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Swine Erysipelas Vaccine Manufacturing Sites and Area Served Table 11. Manufacturers Swine Erysipelas Vaccine Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Swine Erysipelas Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Swine Erysipelas Vaccine as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Swine Erysipelas Vaccine Sales by Region (2016-2021) & (K Units) Table 16. Global Swine Erysipelas Vaccine Sales Market Share by Region (2016-2021) Table 17. Global Swine Erysipelas Vaccine Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Swine Erysipelas Vaccine Sales by Country (2016-2021) & (K Units) Table 19. North America Swine Erysipelas Vaccine Sales Market Share by Country (2016-2021) Table 20. North America Swine Erysipelas Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Swine Erysipelas Vaccine Revenue Market Share by Country (2016-2021) Table 22. Europe Swine Erysipelas Vaccine Sales by Country (2016-2021) & (K Units) Table 23. Europe Swine Erysipelas Vaccine Sales Market Share by Country (2016-2021) Table 24. Europe Swine Erysipelas Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Swine Erysipelas Vaccine Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Swine Erysipelas Vaccine Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Swine Erysipelas Vaccine Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Swine Erysipelas Vaccine Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Swine Erysipelas Vaccine Revenue Market Share by Region (2016-2021) Table 30. Latin America Swine Erysipelas Vaccine Sales by Country (2016-2021) & (K Units) Table 31. Latin America Swine Erysipelas Vaccine Sales Market Share by Country (2016-2021) Table 32. Latin America Swine Erysipelas Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Swine Erysipelas Vaccine Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Swine Erysipelas Vaccine Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Swine Erysipelas Vaccine Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Swine Erysipelas Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Swine Erysipelas Vaccine Revenue Market Share by Country (2016-2021) Table 38. Global Swine Erysipelas Vaccine Sales (K Units) by Type (2016-2021) Table 39. Global Swine Erysipelas Vaccine Sales Market Share by Type (2016-2021) Table 40. Global Swine Erysipelas Vaccine Revenue (Million US$) by Type (2016-2021) Table 41. Global Swine Erysipelas Vaccine Revenue Share by Type (2016-2021) Table 42. Global Swine Erysipelas Vaccine Price (US$/Unit) by Type (2016-2021) Table 43. Global Swine Erysipelas Vaccine Sales (K Units) by Distribution Channel (2016-2021) Table 44. Global Swine Erysipelas Vaccine Sales Market Share by Distribution Channel (2016-2021) Table 45. Global Swine Erysipelas Vaccine Revenue (Million US$) by Distribution Channel (2016-2021) Table 46. Global Swine Erysipelas Vaccine Revenue Share by Distribution Channel (2016-2021) Table 47. Global Swine Erysipelas Vaccine Price (US$/Unit) by Distribution Channel (2016-2021) Table 48. Zoetis Corporation Information Table 49. Zoetis Description and Business Overview Table 50. Zoetis Swine Erysipelas Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 51. Zoetis Swine Erysipelas Vaccine Product Table 52. Zoetis Recent Developments/Updates Table 53. Merck Corporation Information Table 54. Merck Description and Business Overview Table 55. Merck Swine Erysipelas Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 56. Merck Swine Erysipelas Vaccine Product Table 57. Merck Recent Developments/Updates Table 58. Boehringer Ingelheim Corporation Information Table 59. Boehringer Ingelheim Description and Business Overview Table 60. Boehringer Ingelheim Swine Erysipelas Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 61. Boehringer Ingelheim Swine Erysipelas Vaccine Product Table 62. Boehringer Ingelheim Recent Developments/Updates Table 63. Qilu Animal Health Corporation Information Table 64. Qilu Animal Health Description and Business Overview Table 65. Qilu Animal Health Swine Erysipelas Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 66. Qilu Animal Health Swine Erysipelas Vaccine Product Table 67. Qilu Animal Health Recent Developments/Updates Table 68. CAHIC Corporation Information Table 69. CAHIC Description and Business Overview Table 70. CAHIC Swine Erysipelas Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 71. CAHIC Swine Erysipelas Vaccine Product Table 72. CAHIC Recent Developments/Updates Table 73. Chengdu Tianbang Biology Corporation Information Table 74. Chengdu Tianbang Biology Description and Business Overview Table 75. Chengdu Tianbang Biology Swine Erysipelas Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 76. Chengdu Tianbang Biology Swine Erysipelas Vaccine Product Table 77. Chengdu Tianbang Biology Recent Developments/Updates Table 78. Jiujiang Bomeilai Biological Corporation Information Table 79. Jiujiang Bomeilai Biological Description and Business Overview Table 80. Jiujiang Bomeilai Biological Swine Erysipelas Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 81. Jiujiang Bomeilai Biological Swine Erysipelas Vaccine Product Table 82. Jiujiang Bomeilai Biological Recent Developments/Updates Table 83. Jilin Zhengye Biological Corporation Information Table 84. Jilin Zhengye Biological Description and Business Overview Table 85. Jilin Zhengye Biological Swine Erysipelas Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 86. Jilin Zhengye Biological Swine Erysipelas Vaccine Product Table 87. Jilin Zhengye Biological Recent Developments/Updates Table 88. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Corporation Information Table 89. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Description and Business Overview Table 90. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Swine Erysipelas Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 91. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Swine Erysipelas Vaccine Product Table 92. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Recent Developments/Updates Table 93. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Corporation Information Table 94. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Description and Business Overview Table 95. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Swine Erysipelas Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 96. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Swine Erysipelas Vaccine Product Table 97. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Recent Developments/Updates Table 98. Production Base and Market Concentration Rate of Raw Material Table 99. Key Suppliers of Raw Materials Table 100. Swine Erysipelas Vaccine Distributors List Table 101. Swine Erysipelas Vaccine Customers List Table 102. Swine Erysipelas Vaccine Market Trends Table 103. Swine Erysipelas Vaccine Growth Drivers Table 104. Swine Erysipelas Vaccine Market Challenges Table 105. Swine Erysipelas Vaccine Market Restraints Table 106. Global Swine Erysipelas Vaccine Sales Forecast by Type (2022-2027) & (K Units) Table 107. Global Swine Erysipelas Vaccine Sales Market Share Forecast by Type (2022-2027) Table 108. Global Swine Erysipelas Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million) Table 109. Global Swine Erysipelas Vaccine Revenue Market Share Forecast by Type (2022-2027) Table 110. Global Swine Erysipelas Vaccine Sales Forecast by Distribution Channel (2022-2027) & (K Units) Table 111. Global Swine Erysipelas Vaccine Sales Market Share Forecast by Distribution Channel (2022-2027) Table 112. Global Swine Erysipelas Vaccine Revenue Forecast by Distribution Channel (2022-2027) & (US$ Million) Table 113. Global Swine Erysipelas Vaccine Revenue Market Share Forecast by Distribution Channel (2022-2027) Table 114. Global Swine Erysipelas Vaccine Sales Forecast by Region (2022-2027) & (K Units) Table 115. Global Swine Erysipelas Vaccine Sales Market Share Forecast by Region (2022-2027) Table 116. Global Swine Erysipelas Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million) Table 117. Global Swine Erysipelas Vaccine Revenue Market Share Forecast by Region (2022-2027) Table 118. Research Programs/Design for This Report Table 119. Key Data Information from Secondary Sources Table 120. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Swine Erysipelas Vaccine Figure 2. Global Swine Erysipelas Vaccine Market Share by Type in 2020 & 2027 Figure 3. Live Product Picture Figure 4. Inactivated Product Picture Figure 5. Global Swine Erysipelas Vaccine Market Share by Distribution Channel in 2020 & 2027 Figure 6. Pharmacy Figure 7. Online Sale Figure 8. Others Figure 9. Global Swine Erysipelas Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Swine Erysipelas Vaccine Market Size 2016-2027 (US$ Million) Figure 11. Global Swine Erysipelas Vaccine Sales 2016-2027 (K Units) Figure 12. Global Swine Erysipelas Vaccine Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 13. Swine Erysipelas Vaccine Sales Share by Manufacturers in 2020 Figure 14. Global Swine Erysipelas Vaccine Revenue Share by Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Swine Erysipelas Vaccine Players: Market Share by Revenue in 2020 Figure 16. Swine Erysipelas Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 17. Global Swine Erysipelas Vaccine Sales Market Share by Region (2016-2021) Figure 18. Global Swine Erysipelas Vaccine Sales Market Share by Region in 2020 Figure 19. Global Swine Erysipelas Vaccine Revenue Market Share by Region (2016-2021) Figure 20. Global Swine Erysipelas Vaccine Revenue Market Share by Region in 2020 Figure 21. United States Swine Erysipelas Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 22. Canada Swine Erysipelas Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Germany Swine Erysipelas Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. France Swine Erysipelas Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. U.K. Swine Erysipelas Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Italy Swine Erysipelas Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Russia Swine Erysipelas Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. China Swine Erysipelas Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Japan Swine Erysipelas Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. South Korea Swine Erysipelas Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. India Swine Erysipelas Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Australia Swine Erysipelas Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. China Taiwan Swine Erysipelas Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Indonesia Swine Erysipelas Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Thailand Swine Erysipelas Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Malaysia Swine Erysipelas Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Mexico Swine Erysipelas Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Brazil Swine Erysipelas Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Argentina Swine Erysipelas Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Colombia Swine Erysipelas Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Turkey Swine Erysipelas Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Saudi Arabia Swine Erysipelas Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. UAE Swine Erysipelas Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Sales Market Share of Swine Erysipelas Vaccine by Type (2016-2021) Figure 45. Sales Market Share of Swine Erysipelas Vaccine by Distribution Channel (2016-2021) Figure 46. Sales Market Share of Swine Erysipelas Vaccine by Distribution Channel in 2020 Figure 47. Revenue Share of Swine Erysipelas Vaccine by Distribution Channel (2016-2021) Figure 48. Revenue Share of Swine Erysipelas Vaccine by Distribution Channel in 2020 Figure 49. Manufacturing Cost Structure of Swine Erysipelas Vaccine Figure 50. Manufacturing Process Analysis of Swine Erysipelas Vaccine Figure 51. Swine Erysipelas Vaccine Industrial Chain Analysis Figure 52. Channels of Distribution Figure 53. Distributors Profiles Figure 54. Bottom-up and Top-down Approaches for This Report Figure 55. Data Triangulation Figure 56. Key Executives Interviewed

Zoetis Merck Boehringer Ingelheim Qilu Animal Health CAHIC Chengdu Tianbang Biology Jiujiang Bomeilai Biological Jilin Zhengye Biological Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Hunan Zhong'an Biological Pharmaceutical Co., Ltd.